BPC-157: what does the evidence actually show?
BPC-157 has broad preclinical research interest, but the human evidence question remains unresolved. Here is what the evidence actually shows.
Read Article →
Latest Articles
Research Hub
Insights, guides, and articles on peptide research, analytical methods, and best practices.
MG53: why your muscle stem cells stop waking up, and what the research says about fixing it
New research identifies MG53 (TRIM72) as a key regulator of muscle stem cell activation in ageing, and a promising therapeutic…
Read Article →
NAD+: the longevity molecule that just got its biggest scientific endorsement yet
25+ scientists published a coordinated expert review in Nature Aging confirming NAD+ as a central target in aging research. Here's…
Read Article →
VITAL-H: the $38 million human trial that could finally prove longevity drugs work
VITAL-H is a $38 million federally funded trial testing rapamycin, semaglutide, and dapagliflozin in 700–1,000 healthy adults aged 60–65. Here’s…
Read Article →
Thymalin and the Khavinson bioregulator peptides: 40 years of aging research most people haven’t read
Thymalin, Pinealon, and Vilon are ultra-short bioregulator peptides developed over 40 years by Vladimir Khavinson. Here's what the clinical data…
Read Article →
GHK-Cu: the copper peptide with 50 years of research behind it
GHK-Cu is one of the most-studied peptides in existence. Here’s what five decades of research actually shows — mechanism, findings,…
Read Article →
The peptide boom: what The Atlantic got right — and where the story gets more complicated
For laboratory and research use only. The Atlantic published a feature today on the underground peptide market — part of…
Read Article →
Bystander senescence: how senescent cells spread and what it means for senotherapy research
For laboratory and research use only. Introduction Cellular senescence is one of the more active areas in ageing biology right…
Read Article →
Elamipretide (SS-31): the first FDA-approved mitochondrial peptide
On September 19, 2025, a four-amino-acid peptide became the first approved drug to directly target the inside of a mitochondrion.…
Read Article →